April 25, 2025 - 16:28
Delray Beach, FL, April 25, 2025 — The global market for Assisted Reproductive Technology (ART) is on a promising trajectory, with a valuation of approximately $4.02 billion in 2024. Experts predict that this figure will soar to an impressive $6.02 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.0%.
This growth is largely attributed to the increasing prevalence of infertility issues, advancements in reproductive technologies, and a rising awareness of fertility treatments among couples. Additionally, the integration of innovative technologies such as artificial intelligence and genetic testing is enhancing the effectiveness of ART procedures, making them more accessible and appealing to prospective parents.
As societal norms evolve and more individuals seek assistance in family planning, the demand for ART services is expected to continue its upward trend. The market's expansion is also supported by ongoing research and development efforts aimed at improving success rates and patient experiences within fertility clinics worldwide.
